Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.

Lin CH, Yao M, Hsu SC, Ho CC, Lin MT, Lin CA, Hu FC, Yu CJ, Tien HF.

Crit Care Med. 2011 May;39(5):993-9. doi: 10.1097/CCM.0b013e31820a92dc.

PMID:
21283000
2.

Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.

von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, Schmidt-Wolf IG, Marklein G, Schroeder S, Stuber F.

Eur J Clin Microbiol Infect Dis. 2004 Jul;23(7):539-44. Epub 2004 Jun 22.

PMID:
15221617
3.

Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.

Koivula I, Hämäläinen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T, Juutilainen A.

Scand J Infect Dis. 2011 Jul;43(6-7):471-8. doi: 10.3109/00365548.2011.554855. Epub 2011 Feb 7.

PMID:
21299364
4.

The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.

Kaya S, Köksal I, Menteşe A, Sönmez M, Sümer A, Yıldırım SS, Yılmaz G.

Int J Infect Dis. 2013 Nov;17(11):e1056-9. doi: 10.1016/j.ijid.2013.04.004. Epub 2013 Jun 3.

6.

The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.

Miedema KG, de Bont ES, Elferink RF, van Vliet MJ, Nijhuis CS, Kamps WA, Tissing WJ.

Support Care Cancer. 2011 Oct;19(10):1593-600. doi: 10.1007/s00520-010-0987-6. Epub 2010 Aug 28.

7.

[Expression of soluble triggering receptor expressed on myeloid cells-1 in septic patients and its relation with prognosis].

Sun J, Song SD, Zhao HJ.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 May;23(5):305-8. Chinese.

8.

Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.

Persson L, Engervall P, Magnuson A, Vikerfors T, Söderquist B, Hansson LO, Tidefelt U.

Scand J Infect Dis. 2004;36(5):365-71.

PMID:
15287382
10.

Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.

Lin CH, Hsieh SC, Keng LT, Lee HS, Chang HT, Liao WY, Ho CC, Yu CJ.

PLoS One. 2016 Apr 20;11(4):e0153938. doi: 10.1371/journal.pone.0153938. eCollection 2016.

12.

The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.

Erten N, Genc S, Besisik SK, Saka B, Karan MA, Tascioglu C.

J Chin Med Assoc. 2004 May;67(5):217-21.

PMID:
15357107
13.

Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.

Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, Buyukpamukcu M, Yetgin S, Tuncer M, Uludag AK, Tezer H, Yildirim I.

J Pediatr Hematol Oncol. 2007 Feb;29(2):107-11.

PMID:
17279007
14.
15.

Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.

Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B.

Crit Care Med. 2005 Apr;33(4):792-6.

PMID:
15818107
16.

The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.

Debiane L, Hachem RY, Al Wohoush I, Shomali W, Bahu RR, Jiang Y, Chaftari AM, Jabbour J, Al Shuaibi M, Hanania A, Pravinkumar SE, Schuetz P, Raad I.

Crit Care Med. 2014 Dec;42(12):2500-7. doi: 10.1097/CCM.0000000000000526.

PMID:
25083975
17.

Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease.

Shu CC, Lee LN, Wu MF, Lee CH, Wang JT, Wang JY, Yu CJ; TAMI Group..

Int J Tuberc Lung Dis. 2011 Oct;15(10):1415-20. doi: 10.5588/ijtld.10.0786.

PMID:
22283904
18.

Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U.

Intensive Care Med. 2000 Mar;26 Suppl 2:S202-11. doi: 10.1007/BF02900739.

PMID:
18470721
19.

Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study.

Li Z, Wang H, Liu J, Chen B, Li G.

Mediators Inflamm. 2014;2014:641039. doi: 10.1155/2014/641039. Epub 2014 Feb 4.

20.

Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.

Chayakulkeeree M, Thamlikitkul V.

J Med Assoc Thai. 2003 Mar;86(3):212-23.

PMID:
12757060

Supplemental Content

Support Center